November 8, 2009
Pharmacosmos participates in the joint ECCO 15 - 34th ESMO
Multidisciplinary Congress. The congress is held in Berlin, Germany
during the period 20th to 24th September 2009. The congress is a
joint meeting with ECCO - the European Cancer Organisation and ESMO
- the European Society for Medical Oncology. For further
information about the congress, we refer to www.ecco-org.eu.
About Pharmacosmos A/S
Pharmacosmos develops and markets
medicines for the treatment of iron deficiency. A research-based
company, its ongoing R&D programme focuses on improving the
treatment options for healthcare professionals and patients
suffering from iron deficiency.
Pharmacosmos is a privately-owned
Danish company and operates in more than 50 countries across
Europe, the Americas and Asia. Its facilities are approved by the
Danish Medicines Agency and the US Food & Drug
Administration.